Anders Lindblad
Overview
Explore the profile of Anders Lindblad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
451
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hansen C, Gilljam M, Olesen H, Hoiby N, Karpati F, Johansson E, et al.
Acta Paediatr
. 2021 Apr;
110(9):2607-2609.
PMID: 33866605
No abstract available.
12.
Colombo C, Alicandro G, Oliver M, Lewindon P, Ramm G, Ooi C, et al.
J Cyst Fibros
. 2021 Apr;
21(2):220-226.
PMID: 33814323
Background: The efficacy and safety of ursodeoxycholic acid (UDCA) for the treatment of liver disease associated with cystic fibrosis (CF) are under discussion, and clinical practice varies among centers. The...
13.
Oshalim M, Johansson E, Rabe H, Gilljam M, Lindblad A, Jonsson B
Pathog Dis
. 2020 Sep;
78(6).
PMID: 32876666
Cystic fibrosis (CF) is a genetic disease leading to chronic bacterial airway infection and inflammation. T helper 17 (Th17) cells are identified by their production of interleukin (IL)-17A, which recruit...
14.
Gustafsson P, Kadar L, Kjellberg S, Andersson L, Lindblad A, Robinson P
Physiol Rep
. 2020 Aug;
8(16):e14477.
PMID: 32845567
We have previously shown that functional residual capacity (FRC) and lung clearance index were significantly greater in sleeping healthy infants when measured by N (nitrogen) washout using 100% O (oxygen)...
15.
Svedberg M, Gustafsson P, Tiddens H, Imberg H, Pivodic A, Lindblad A
J Cyst Fibros
. 2019 Nov;
19(6):910-916.
PMID: 31672554
Background: Computed tomography (CT) is used to monitor progression of structural lung disease (SLD) in children with cystic fibrosis (CF). Our goals were to identify the risk factors for the...
16.
Robinson P, Kadar L, Lindblad A, Gustafsson P
Eur Respir J
. 2019 Aug;
54(6).
PMID: 31467118
No abstract available.
17.
Gustafsson P, Bengtsson L, Lindblad A, Robinson P
J Appl Physiol (1985)
. 2017 Sep;
123(6):1545-1554.
PMID: 28860172
The detrimental effects on breathing pattern during multiple breath inert gas washout (MBW) have been described with different inhaled gases [100% oxygen (O) and sulfur hexafluoride (SF)] but detailed comparisons...
18.
Svedberg M, Gustafsson P, Robinson P, Rosberg M, Lindblad A
J Cyst Fibros
. 2017 Aug;
17(2):236-241.
PMID: 28822728
Background: Data on long term variability of Lung Clearance Index (LCI) in Cystic Fibrosis (CF) is urgently needed to guide test result interpretation. Our aim was to evaluate LCI variability...
19.
Elborn J, Bell S, Madge S, Burgel P, Castellani C, Conway S, et al.
Eur Respir J
. 2015 Oct;
47(2):420-8.
PMID: 26453627
The improved survival in people with cystic fibrosis has led to an increasing number of patients reaching adulthood. This trend is likely to be maintained over the next decades, suggesting...
20.
Subbarao P, Milla C, Aurora P, Davies J, Davis S, Hall G, et al.
Ann Am Thorac Soc
. 2015 Jun;
12(6):932-9.
PMID: 26075554
The lung clearance index (LCI) is a lung function parameter derived from the multiple-breath washout (MBW) test. Although first developed 60 years ago, the technique was not widely used for...